hit counter

Cymbalta Lawsuits: Users Suing Eli Lilly Over Undisclosed Withdrawal Symptoms

It appears as though the pharmaceutical juggernaut Eli Lilly is facing major legal backlash for failure to disclose discontinuation effects associated with their medication Cymbalta (Duloxetine).  Cymbalta is an SNRI antidepressant that was approved in August 2004 for the treatment of major depression.  A woman named Claudia Herrera has been making news headlines because she …

Read more

LY-2456302 For Depression: Kappa Opioid Receptor (KOR) Antagonist

In recent years, biotech and pharmaceutical companies have been developing new classes of antidepressants. These new classes attempt to improve on older classes of medication in regards to efficacy, side effects, and tolerability. One such class that is being developed is that which targets opioid receptors, particularly the kappa receptor. These drugs are classified as …

Read more